Fri, Jul 25, 2014, 3:16 PM EDT - U.S. Markets close in 44 mins.


% | $
Click the to save as a favorite.

Regenerx Biopharmaceuticals Inc. Message Board

  • snogreen snogreen Jun 6, 2011 1:35 PM Flag

    Unenthused PR

    Just goes to show ya'..mgmt reads this board. Not tehe first time research stuff is shown first here...and mgmt scrambles after to then make it public. But it was public already. You just have to look.

    So there you have it. They followed up with what I found. Except the whole thing was underplayed. You had a pre-eminint place doing it. RGN FAILED to mention that this research was "Peer Reviewed"....which means a panel had to review all data and stuff befere they accept it. Only the best gets thru Peer Review.

    RGN faild to say that The American Heart Association was a major sponsor of this work of TB 4 in heart area.

    RGN failed to say that the N.I.H. also helped fund this work.

    I think this was some pretty important work, that may help in locating a partnetr for trials. But it's like RGN mgmt comes down kicking and screaming NOT to do decent releases....and they clearly didn't want to.... until I showed the <<<public data first>>>.

    ANY other tiny biotech would write a release that sounds exciting at the prospects...and WHO did it..and WHO funded it.

    But oooooh noooo. Not RGN. Only the minimum necessary.

    The ONLY thing they can do to the maximium.....are their own compensations and PIPE deals.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.163+0.001(+0.62%)Jul 25 12:33 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.